1998
DOI: 10.1155/s106474499800043x
|View full text |Cite
|
Sign up to set email alerts
|

Persistence of Human Papillomavirus DNA inCervical Lesions After Treatment With DiathermicLarge Loop Excision

Abstract: Objective: The aim of this study was to identify human papillomavirus (HPV)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
10
0
3

Year Published

2000
2000
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 14 publications
3
10
0
3
Order By: Relevance
“…PCR with generic primers, combined with single-stranded conformational polymorphism (SSCP) analysis, has been applied to HPV detection and typing in cervical samples [Lizano et al, 1997;Distéfano et al, 1998]. …”
Section: Introductionmentioning
confidence: 99%
“…PCR with generic primers, combined with single-stranded conformational polymorphism (SSCP) analysis, has been applied to HPV detection and typing in cervical samples [Lizano et al, 1997;Distéfano et al, 1998]. …”
Section: Introductionmentioning
confidence: 99%
“…Successful treatment for CIN is associated with HPV clearance (11). HPV DNA persistence is known to be a near-necessary risk factor for CIN (3,4,15,21,24,34,40), and as expected, posttreatment presence of HR-HPV is a good marker for recurrence (10,17), better than abnormal cytology (26).…”
Section: Discussionmentioning
confidence: 92%
“…Os autores não detectaram o DNA-HPV nas 22 pacientes sem recidiva após a conização pertencentes ao grupo controle. Da mesma forma, Distefano et al 11 …”
Section: Discussionunclassified
“…Não se sabe entretanto, se a detecção do DNA-HPV após o tratamento da NIC, pode ser utilizada como fator clí-nico preditivo de persistência ou recidiva da doença. Muitos autores acreditam que a detecção do DNA-HPV ajuda a selecionar as mulheres que apresentarão recidiva, porém outros não verificaram associação entre a detecção viral e a presença de doença residual ou recorrente [9][10][11][12][13][14][15] .…”
Section: Introductionunclassified
See 1 more Smart Citation